跳至主要内容
临床试验/NCT07819370
NCT07819370尚未招募4 期

Early Enamel Lesion Detection and Management With a New Diagnostic Tool

Colgate Palmolive1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2026年9月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
5
试验地点
1
主要终点
Enamel Lesions per BlueCheck

研究概览

简要总结

The primary objective of this 12-week study is to test BlueCheck's ability to identify enamel lesions consistently, and its ability to track changes in these lesions over time.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
13 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed Informed Consent/Assent Form.
  • Male and female subjects aged 13 years or older.
  • Availability for the duration of the study.
  • Good general health and good oral health based on the opinion of the study investigator.
  • Subjects must have active enamel lesions and no cavities requiring immediate restoration in the mouth.
  • Subjects must be candidates for high fluoride toothpaste treatment.

排除标准

  • Subjects with fixed or removable orthodontic appliances or removable partial dentures.
  • Obvious signs of periodontal disease or any condition that the dental examiner considers exclusionary from the study.
  • Cavities.
  • Concurrent participation in another oral clinical study.
  • Self-reported pregnant and/or lactating women, or those planning to become pregnant during the study.
  • History of allergies or sensitivity to personal care consumer products or their ingredients.
  • Medical condition which requires premedication prior to dental visits/procedure.
  • Significant oral soft tissue pathology, excluding plaque-induced gingivitis.
  • Dental prophylaxis within 30 days prior to study start.
  • Subjects who must receive dental treatment during the study dates.
  • Immunocompromised individuals (HIV, AIDS, immunosuppressive drug therapy).
  • Use of smokeless tobacco, vaping, or e-cigarettes or suspected substance abuse.
  • Current smokers (if former smoker, should have stopped at least 1 month prior to Visit 1).
  • Subjects who have an infectious disease and/or other blood borne diseases (Hepatitis series, HIV, tuberculosis).

研究组 & 干预措施

Test Group

Experimental

This is a monadic study with one arm. All subjects will receive the intervention.

干预措施: BlueCheck (Device)

Test Group

Experimental

This is a monadic study with one arm. All subjects will receive the intervention.

干预措施: Prevident 5000ppm Booster Plus Toothpaste (Drug)

结局指标

主要结局

Enamel Lesions per BlueCheck

时间窗: Baseline, 4 weeks, and 12 weeks

Number of enamel lesions counted after using BlueCheck

次要结局

  • Self-perceived reactions to BlueCheck application(Baseline, 4 weeks, and 12 weeks)
  • Enamel Lesions per Xray(Baseline, 4 weeks, and 12 weeks)
  • Enamel lesions per intraoral camera(Baseline, 4 weeks, and 12 weeks)
  • White spots(Baseline, 4 weeks, and 12 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验